Cardinal Health, Inc. (NYSE:CAH) Stock Holdings Boosted by Kapstone Financial Advisors LLC

Kapstone Financial Advisors LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 4,366 shares of the company’s stock after acquiring an additional 195 shares during the period. Kapstone Financial Advisors LLC’s holdings in Cardinal Health were worth $462,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of CAH. Cornerstone Planning Group LLC bought a new position in shares of Cardinal Health during the third quarter worth about $26,000. BKM Wealth Management LLC bought a new position in Cardinal Health in the 4th quarter valued at about $30,000. Wetzel Investment Advisors Inc. bought a new position in Cardinal Health in the 4th quarter valued at about $36,000. Headlands Technologies LLC bought a new position in Cardinal Health in the 3rd quarter valued at about $47,000. Finally, McGlone Suttner Wealth Management Inc. bought a new position in Cardinal Health in the 4th quarter valued at about $59,000. Institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. UBS Group increased their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Leerink Partnrs reiterated an “outperform” rating on shares of Cardinal Health in a research report on Monday, February 26th. Barclays assumed coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 target price for the company. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Finally, SVB Leerink initiated coverage on shares of Cardinal Health in a report on Monday, February 26th. They issued an “outperform” rating and a $125.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $103.07.

Cardinal Health Trading Down 0.6 %

CAH stock traded down $0.60 during mid-day trading on Friday, reaching $103.21. 1,399,916 shares of the stock traded hands, compared to its average volume of 1,705,735. Cardinal Health, Inc. has a 52-week low of $77.56 and a 52-week high of $116.04. The company has a market cap of $25.10 billion, a P/E ratio of 40.63, a P/E/G ratio of 1.04 and a beta of 0.68. The stock’s fifty day moving average is $109.51 and its 200-day moving average is $104.76.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The company had revenue of $57.45 billion during the quarter, compared to analyst estimates of $57.02 billion. During the same period in the prior year, the firm earned $1.32 earnings per share. The business’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts expect that Cardinal Health, Inc. will post 7.28 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 78.74%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.